Illumina Announces Preliminary Revenue for Third Quarter of Fiscal Year 2016
October 10 2016 - 4:05PM
Business Wire
Illumina, Inc. (NASDAQ: ILMN) today announced estimated third
quarter revenue of approximately $607 million, a 10% increase
compared to $550 million in the third quarter of 2015.
This unaudited estimate, based on management's preliminary
financial analysis, is lower than the third quarter revenue
guidance of $625 million to $630 million.
The shortfall in quarterly revenue was driven by a larger than
anticipated year-over-year decline in high throughput sequencing
instruments. As a result, the company expects fourth quarter
revenue will be flat to slightly up sequentially.
Pre-Announcement Conference Call Details
A brief conference call to discuss preliminary third quarter
results will be held today, October 10, 2016, at 1:30 pm Pacific
Time (4:30 pm Eastern Time). Interested parties may listen to the
call by dialing 888.771.4371 (passcode: 43578941), or if outside
North America by dialing +1.847.585.4405 (passcode: 43578941).
Individuals may access the live teleconference in the Investor
Relations section of Illumina’s web site under the “company” tab at
www.illumina.com.
A replay of the conference call will be available from 4:00 pm
Pacific Time (7:00 pm Eastern Time) on October 10, 2016 through
October 17, 2016 by dialing 888.843.7419 (passcode: 43578941), or
if outside North America by dialing +1.630.652.3042 (passcode:
43578941).
Third Quarter Results Conference Call Details
Results for third quarter 2016 will be issued following the
close of market on Tuesday, November 1, 2016. On the same day, at
2:00 pm Pacific Time (5:00 pm Eastern Time) Francis deSouza,
President and CEO, and Marc Stapley, Executive Vice President,
Chief Administrative Officer, and Chief Financial Officer, will
host a conference call to discuss financial and operating
results.
Interested parties may listen to the call by dialing
888.771.4371 (passcode: 43579048), or if outside North America by
dialing +1.847.585.4405 (passcode: 43579048). Individuals may
access the live teleconference in the Investor Relations section of
Illumina’s web site under the “company” tab at
www.illumina.com.
A replay of the conference call will be available from 4:30 pm
Pacific Time (7:30 pm Eastern Time) on November 1, 2016 through
November 8, 2016 by dialing 888.843.7419 (passcode: 43579048), or
if outside North America by dialing +1.630.652.3042 (passcode:
43579048).
Use of forward-looking statements
This release contains projections, information about our
financial outlook, earnings guidance, and other forward-looking
statements that involve risks and uncertainties. These
forward-looking statements are based on our expectations as of the
date of this release and may differ materially from actual future
events or results. Among the important factors that could cause
actual results to differ materially from those in any
forward-looking statements are (i) our ability to further develop
and commercialize our instruments and consumables and to deploy new
products, services and applications, and expand the markets for our
technology platforms; (ii) our ability to manufacture robust
instrumentation and consumables; (iii) our ability to successfully
identify and integrate acquired technologies, products or
businesses; (iv) the future conduct and growth of the business and
the markets in which we operate; (v) challenges inherent in
developing, manufacturing, and launching new products and services;
and (vi) the application of generally accepted accounting
principles, which are highly complex and involve many subjective
assumptions, estimates, and judgments, together with other factors
detailed in our filings with the Securities and Exchange
Commission, including our most recent filings on Forms 10-K and
10-Q, or in information disclosed in public conference calls, the
date and time of which are released beforehand. We undertake no
obligation, and do not intend, to update these forward-looking
statements, to review or confirm analysts’ expectations, or to
provide interim reports or updates on the progress of the current
quarter.
About Illumina
Illumina is improving human health by unlocking the power of the
genome. Our focus on innovation has established us as the global
leader in DNA sequencing and array-based technologies, serving
customers in the research, clinical and applied markets. Our
products are used for applications in the life sciences, oncology,
reproductive health, agriculture and other emerging
segments. To learn more, visit www.illumina.com and
follow @illumina.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161010006110/en/
Illumina, Inc.Investors:Rebecca
Chambers858.255.5243ir@illumina.comorMedia:Eric
Endicott858.882.6822pr@illumina.com
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Illumina (NASDAQ:ILMN)
Historical Stock Chart
From Sep 2023 to Sep 2024